Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer
- PMID: 23355336
- DOI: 10.1007/s13277-013-0667-5
Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer
Abstract
Lymph node metastasis is a major prognostic factor in resected non-small cell lung cancer (NSCLC). However, 30-40 % rate of recurrence after performing complete resection in node-negative patients suggests that their nodal staging is suboptimal. We aimed to evaluate the molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with node-negative NSCLC. Primary tumor samples from 62 patients with resected stage I-IIB NSCLC were screened for fragile histidine triad (FHIT) and CDKN2A mRNA deletion using reverse transcriptase polymerase chain reaction (RT-PCR). The molecular alternations were found in tumors of 49 patients. A total of 269 lymph nodes from these 49 NSCLC patients with FHIT or/and CDKN2A deletion tumors were examined. Fifteen positive-control nodes and ten negative-control nodes were also analyzed for FHIT and CDKN2A mRNA deletion. Thirty-nine (22 %) and 22 (18 %) lymph nodes from the 49 patients with FHIT and CDKN2A mRNA deletion in primary tumor had FHIT and CDKN2A mRNA deletion, respectively. The types of FHIT and CDKN2A mRNA deletion in lymph nodes were identical with those in their primary tumors. By combination of two markers, 16 patients (32.7 %) were found to have nodal micrometastasis. Survival analysis showed that patients with nodal micrometastasis had reduced disease-free survival (P = 0.001) and overall survival (P = 0.002) rates. Multivariate analysis demonstrated that nodal micrometastasis was an independent predictor for worse prognosis. Thus, the detection of lymph node micrometastasis by FHIT and CDKN2A mRNA deletion RT-PCR will be helpful to predict the recurrence and prognosis of patients with completely resected stage I-IIB NSCLC.
Similar articles
-
Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.Clin Transl Oncol. 2013 Nov;15(11):882-8. doi: 10.1007/s12094-013-1017-1. Epub 2013 Feb 12. Clin Transl Oncol. 2013. PMID: 23404657
-
Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.J Cancer Res Clin Oncol. 2016 Jan;142(1):263-72. doi: 10.1007/s00432-015-2040-0. Epub 2015 Aug 30. J Cancer Res Clin Oncol. 2016. PMID: 26319393 Free PMC article.
-
Decreased fragile histidine triad gene messenger RNA expression in lung cancer.Clin Lung Cancer. 2006 May;7(6):412-6. doi: 10.3816/CLC.2006.n.026. Clin Lung Cancer. 2006. PMID: 16800968
-
Lymph node micrometastasis in non-small cell lung cancer.Biomed Pharmacother. 2022 May;149:112817. doi: 10.1016/j.biopha.2022.112817. Epub 2022 Mar 15. Biomed Pharmacother. 2022. PMID: 35303567 Review.
-
Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.Oncotarget. 2017 Jan 24;8(4):6845-6856. doi: 10.18632/oncotarget.14256. Oncotarget. 2017. PMID: 28036263 Free PMC article. Review.
Cited by
-
Detection of occult tumor cells in regional lymph nodes is associated with poor survival in pN0 non-small cell lung cancer: a meta-analysis.J Thorac Dis. 2016 Mar;8(3):375-85. doi: 10.21037/jtd.2016.02.52. J Thorac Dis. 2016. PMID: 27076932 Free PMC article.
-
Prognostic factors in resected lung carcinomas.EJC Suppl. 2013 Sep;11(2):137-49. doi: 10.1016/j.ejcsup.2013.07.023. EJC Suppl. 2013. PMID: 26217123 Free PMC article. Review. No abstract available.
-
The clinical value of a new method of functional lymph node dissection in video-assisted thoracic surgery right non-small cell lung cancer radical resection.J Thorac Dis. 2019 Feb;11(2):477-487. doi: 10.21037/jtd.2019.01.15. J Thorac Dis. 2019. PMID: 30962991 Free PMC article.
-
Microcomputed tomography as a diagnostic tool for detection of lymph node metastasis in non-small cell lung cancer: A decision-support approach for pathological examination "A pilot study for method validation".J Pathol Inform. 2024 Mar 24;15:100373. doi: 10.1016/j.jpi.2024.100373. eCollection 2024 Dec. J Pathol Inform. 2024. PMID: 38633838 Free PMC article.
-
Longitudinal study on circulating miRNAs in patients after lung cancer resection.Oncotarget. 2015 Jun 30;6(18):16674-85. doi: 10.18632/oncotarget.4322. Oncotarget. 2015. PMID: 26078336 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous